Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma

Summary

This is a multi-center, randomized, controlled, open-label, phase IIa clinical study.The study will observe the efficacy and safety of Deuteporfin photodynamic therapy in addition to stenting compared to stenting alone in patients with unresectable advanced Perihilar Cholangiocarcinoma.

Timeline

Start

2017-05-17

Primary completion

2018-12-26

Completion

2018-12-26

Outcome

Outcome not reported

Stopped (Business): “Business Decision”

Drugs

Indications